Following is true about medullobastoma:
**Core Concept**
Medulloblastoma is a highly malignant primary brain tumor that originates in the cerebellum or posterior fossa, primarily in children. It is a type of primitive neuroectodermal tumor (PNET) that is characterized by its rapid growth and tendency to spread through the cerebrospinal fluid (CSF) pathways.
**Why the Correct Answer is Right**
Medulloblastomas are often associated with the Wnt/β-catenin signaling pathway, which plays a crucial role in their development and progression. The tumor cells frequently exhibit mutations in the CTNNB1 gene, leading to the accumulation of β-catenin in the nucleus, which in turn activates the transcription of target genes involved in cell proliferation and survival. The tumor's aggressiveness and tendency to spread through the CSF pathways are thought to be related to the expression of specific surface markers and the ability of tumor cells to invade and migrate along the CSF pathways.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because medulloblastomas are not typically associated with the PI3K/AKT signaling pathway, which is more commonly implicated in other types of brain tumors, such as glioblastomas.
**Option B:** This option is incorrect because medulloblastomas do not typically arise from the cerebral cortex, which is more commonly associated with other types of brain tumors, such as gliomas.
**Option C:** This option is incorrect because medulloblastomas are not typically characterized by their slow growth and low tendency to spread, but rather by their rapid growth and tendency to disseminate through the CSF pathways.
**Clinical Pearl / High-Yield Fact**
Medulloblastomas are often classified into four molecular subgroups based on their genetic and epigenetic profiles: WNT, SHH, Group 3, and Group 4. Understanding the molecular characteristics of these subgroups is crucial for developing targeted therapies and improving patient outcomes.
**Correct Answer: D.**